Literature DB >> 21183586

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

Sharon M Moe1, Miriam P Zidehsarai, Mary A Chambers, Lisa A Jackman, J Scott Radcliffe, Laurie L Trevino, Susan E Donahue, John R Asplin.   

Abstract

BACKGROUND AND OBJECTIVES: Patients with advanced chronic kidney disease (CKD) are in positive phosphorus balance, but phosphorus levels are maintained in the normal range through phosphaturia induced by increases in fibroblast growth factor-23 (FGF23) and parathyroid hormone (PTH). This provides the rationale for recommendations to restrict dietary phosphate intake to 800 mg/d. However, the protein source of the phosphate may also be important. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a crossover trial in nine patients with a mean estimated GFR of 32 ml/min to directly compare vegetarian and meat diets with equivalent nutrients prepared by clinical research staff. During the last 24 hours of each 7-day diet period, subjects were hospitalized in a research center and urine and blood were frequently monitored.
RESULTS: The results indicated that 1 week of a vegetarian diet led to lower serum phosphorus levels and decreased FGF23 levels. The inpatient stay demonstrated similar diurnal variation for blood phosphorus, calcium, PTH, and urine fractional excretion of phosphorus but significant differences between the vegetarian and meat diets. Finally, the 24-hour fractional excretion of phosphorus was highly correlated to a 2-hour fasting urine collection for the vegetarian diet but not the meat diet.
CONCLUSIONS: In summary, this study demonstrates that the source of protein has a significant effect on phosphorus homeostasis in patients with CKD. Therefore, dietary counseling of patients with CKD must include information on not only the amount of phosphate but also the source of protein from which the phosphate derives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183586      PMCID: PMC3052214          DOI: 10.2215/CJN.05040610

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  33 in total

Review 1.  Current issues in the management of secondary hyperparathyroidism and bone disease.

Authors:  S M Moe
Journal:  Perit Dial Int       Date:  2001       Impact factor: 1.756

2.  Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

Authors:  Serge L Ferrari; Jean-Philippe Bonjour; René Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

3.  Serum phosphate levels and mortality risk among people with chronic kidney disease.

Authors:  Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2004-12-22       Impact factor: 10.121

4.  Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease.

Authors:  R Narang; D Ridout; C Nonis; J S Kooner
Journal:  Int J Cardiol       Date:  1997-06-27       Impact factor: 4.164

5.  Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis.

Authors:  J Kyriazis; D Stamatiadis; A Mamouna
Journal:  Am J Kidney Dis       Date:  2000-06       Impact factor: 8.860

6.  Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Authors:  Orlando Gutierrez; Tamara Isakova; Eugene Rhee; Anand Shah; Julie Holmes; Gina Collerone; Harald Jüppner; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

7.  Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

Authors:  Eric W Young; Justin M Albert; Sudtida Satayathum; David A Goodkin; Ronald L Pisoni; Takashi Akiba; Tadao Akizawa; Kiyoshi Kurokawa; Jürgen Bommer; Luis Piera; Friedrich K Port
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

8.  Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.

Authors:  A A Portale; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

9.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Medial arterial calcification and diabetic neuropathy.

Authors:  M E Edmonds; N Morrison; J W Laws; P J Watkins
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27
View more
  159 in total

1.  Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.

Authors:  Jessica Houston; Kelsey Smith; Tamara Isakova; Nicole Sowden; Myles Wolf; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

Review 2.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.

Authors:  L Darryl Quarles
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

3.  Phosphate toxicity: a stealth biochemical stress factor?

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Med Mol Morphol       Date:  2015-11-18       Impact factor: 2.309

4.  Dietary Protein as Kidney Protection: Quality or Quantity?

Authors:  Nimrit Goraya; Donald E Wesson
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

Review 5.  Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla; Myles Wolf
Journal:  Nat Rev Nephrol       Date:  2014-04-01       Impact factor: 28.314

Review 6.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Authors:  Makoto Kuro-o
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

Review 7.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

8.  Fibroblast Growth Factor-23 and a Vegetarian Diet.

Authors:  Shuchi Anand; Ram Jagannathan; Ruby Gupta; Sailesh Mohan; Dorairaj Prabhakaran; Myles Wolf
Journal:  J Ren Nutr       Date:  2020-04-01       Impact factor: 3.655

9.  24-hour urine phosphorus excretion and mortality and cardiovascular events.

Authors:  Heather L Palomino; Dena E Rifkin; Cheryl Anderson; Michael H Criqui; Mary A Whooley; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

10.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.